The implementation of screening for prostate cancer

P J van Leeuwen1, H A van Vugt, C H Bangma

  • 1Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands. p.vanleeuwen@erasmusmc.nl

Summary

Prostate cancer (PC) screening may reduce mortality, but limited data on costs and quality of life mean it cannot yet be recommended for public health policy.